Patents by Inventor Peter Hnik

Peter Hnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PROTEASOME INHIBITORS IN THE TREATMENT OF CORONAVIRUS INFECTIONS
    Publication number: 20240115588
    Abstract: Oral formulations comprising one or more proteasome inhibitors for use as a treatment of coronavirus infection in a subject. Also disclosed are the use of such for the treatment or prevention of SARS-CoV-2 infection in humans.
    Type: Application
    Filed: February 1, 2022
    Publication date: April 11, 2024
    Applicants: Board of Supervisors of Louisiana state University and Agricultural and Mechanical College, Skymount Medical US lnc.
    Inventors: Adam Bess, Frej Knut Gosta BERGLIND, Supratik MUKHOPADHYAY, Kishor M. WASAN, Chris GALLIANO, Michal BRYLINSKI, Stephania CORMIER, Allan ADER, Nicholas GRIGGS, Janet GOULD, Tiffany CHO, Julia ABRAMOV, Peter HNIK
  • METHODS OF TREATING CORONAVIRUS DISEASE AND COMPOUNDS FOR SAME
    Publication number: 20230398114
    Abstract: A tyrosine kinase inhibitor for use in the treatment of COVID-19 and/or its associated symptoms. Also disclosed is a method of treating an individual infected with a coronavirus, wherein said method comprises the steps of: providing a tyrosine kinase inhibitor; and administering said tyrosine kinase inhibitor to said individual in a dosage amount sufficient to prevent/stabilize/reduce the risks and/or symptoms associated with a coronavirus infection.
    Type: Application
    Filed: November 2, 2021
    Publication date: December 14, 2023
    Inventors: Kishor M. WASAN, Chris GALLIANO, Supratik MUKHOPADHYAY, Adam BESS, Frej Knut Gosta BERGLIND, Stephania CORMIER, Allan ADER, Nicholas GRIGGS, Janet GOULD, Tiffany CHO, Julia ABRAMOV, Peter HNIK, Michal BRYLINSKI
  • SOLID ORAL FORMULATIONS OF AMPHOTERICIN B
    Publication number: 20210369615
    Abstract: The present disclosure describes methods of treating infectious diseases with solid dosage forms comprising amphotericin B. In some embodiments, the disclosure provides methods of treating fungal infections and Lesishmania infection.
    Type: Application
    Filed: July 31, 2019
    Publication date: December 2, 2021
    Inventors: Peter HNIK, Roch THIBERT, Aimesther BETANCOURT
  • STABLE FORMULATIONS FOR THE ORAL ADMINISTRATION OF AMPHOTERICIN B AND RELATED METHODS
    Publication number: 20200281958
    Abstract: The present invention provides oral AmpB and/or protease inhibitor formulations and their use to treat infectious disease, including HIV.
    Type: Application
    Filed: October 15, 2019
    Publication date: September 10, 2020
    Inventor: Peter HNIK
  • SOLID ORAL FORMULATIONS OF AMPHOTERICIN B
    Publication number: 20200155583
    Abstract: The present disclosure describes solid dosage forms comprising amphotericin B. Also described herein are methods of treating fungal infections and Lesishmania infections.
    Type: Application
    Filed: February 21, 2018
    Publication date: May 21, 2020
    Inventors: Peter HNIK, Roch THIBERT, Aimesther BETANCOURT
  • STABLE FORMULATIONS FOR THE ORAL ADMINISTRATION OF AMPHOTERICIN B AND RELATED METHODS
    Publication number: 20180000854
    Abstract: The present invention provides oral AmpB and/or protease inhibitor formulations and their use to treat infectious disease, including HIV.
    Type: Application
    Filed: January 8, 2016
    Publication date: January 4, 2018
    Inventor: Peter Hnik
  • DOSING REGIMENS FOR TREATING AND PREVENTING OCULAR DISORDERS USING C-RAF ANTISENSE
    Publication number: 20130028889
    Abstract: The present invention provides methods and dosing regimens for treating and preventing ocular disorders using c-raf antisense oligonucleotides, alone or in combination with other agents.
    Type: Application
    Filed: February 3, 2011
    Publication date: January 31, 2013
    Applicant: ICO THERAPEUTICS INC.
    Inventors: Peter Hnik, John G. Clement
  • Treatment of macular edema
    Patent number: 7015240
    Abstract: The invention relates to the use of photodynamic therapy (PDT) to treat macular edemas, including DME, CRVO and BRVO. It provides an alternative to photocoagulation and the disadvantages associated therewith.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: March 21, 2006
    Assignee: QLT, Inc.
    Inventors: Janice North, Peter Hnik, H. Andrew Strong
  • Treatment of macular edema
    Publication number: 20040019032
    Abstract: The invention relates to the use of photodynamic therapy (PDT) to treat macular edemas, including DME, CRVO and BRVO. It provides an alternative to photocoagulation and the disadvantages associated therewith.
    Type: Application
    Filed: July 17, 2003
    Publication date: January 29, 2004
    Inventors: Janice North, Peter Hnik, H. Andrew Strong
  • Treatment of macular edema
    Patent number: 6599891
    Abstract: The invention relates to the use of photodynamic therapy (PDT) to treat macular edemas, including DME, CRVO and BRVO. It provides an alternative to photocoagulation and the disadvantages associated therewith.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: July 29, 2003
    Assignee: QLT Inc.
    Inventors: Janice North, Peter Hnik, H. Andrew Strong
  • Treatment of macular edema
    Publication number: 20030099596
    Abstract: The invention relates to the use of photodynamic therapy (PDT) to treat macular edemas, including DME, CRVO and BRVO. It provides an alternative to photocoagulation and the disadvantages associated therewith.
    Type: Application
    Filed: July 19, 2002
    Publication date: May 29, 2003
    Inventors: Janice North, Peter Hnik, H. Andrew Strong